Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Detroit, MI

55 studies for Prostate Cancer are recruiting at 219 sites within 50 miles of Detroit, Michigan, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Detroit.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Detroit

Showing the 50 nearest of 55 studies.
  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Hospital (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    45 sites within 50 mi
  2. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    NCT03866382

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Henry Ford Hospital (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    26 sites within 50 mi
  3. Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

    NCT06470243

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Henry Ford Health Saint John Hospital (Detroit, MI); Great Lakes Cancer Management Specialists-Van Elslander Cancer Center (Grosse Pointe Woods, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    25 sites within 50 mi
  4. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Henry Ford Hospital (Detroit, MI); Wayne State University/Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  5. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Henry Ford Hospital (Detroit, MI); Henry Ford Medical Center - Detroit Northwest (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  6. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Henry Ford Hospital (Detroit, MI); Corewell Health Dearborn Hospital (Dearborn, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  7. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Henry Ford Hospital (Detroit, MI); Wayne State University/Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    13 sites within 50 mi
  8. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    NCT07200830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Henry Ford Hospital (Detroit, MI); Henry Ford Medical Center-Fairlane (Dearborn, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  9. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Exelixis Clinical Site #13 (Detroit, MI); Exelixis Clinical Site #65 (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    NCT06925737

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Henry Ford Hospital ( Site 0035) (Detroit, MI); University of Michigan ( Site 0005) (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Henry Ford Cancer Detroit (Detroit, MI); University of Michigan Health System (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    NCT07181161

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: Male

    Nearest sites: Research Site (Detroit, MI); Research Site (Ann Arbor, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    NCT03972657

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Health (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Study of ORIC-944 in Patients With Metastatic Prostate Cancer

    NCT05413421

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Karmanos (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

    NCT05914116

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Research Site 129 (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Henry Ford Hospital ( Site 0015) (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

    NCT06190899

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Barbara Ann Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Sacral Neuromodulation for Male Overactive Bladder (MOAB)

    NCT06511141

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Wayne State University (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

    NCT06785636

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

    NCT06855277

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    NCT07114601

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Barbara Ann Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and Intermediate-risk Prostate Cancers.

    NCT07348367

    • Interventional
    • Ages Any age
    • Sex: Male

    Nearest site: Henry Ford Health (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

    NCT07436078

    • Interventional
    • Ages 20 to 79 years
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    NCT07503808

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Karmanos Cancer Institute (Detroit, MI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

    NCT04052048

    • Observational
    • Ages 40 to 80 years
    • Sex: Male

    Nearest site: Comprehensive Urology (Royal Oak, MI)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    NCT05803941

    • Phase 4
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Corewell Health William Beaum Hosp (Royal Oak, MI)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

    NCT05939414

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: William Beaumont Hospital (Royal Oak, MI)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

    NCT07006727

    • Phase 1
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: Corewell Health William Beaum Hosp (Royal Oak, MI)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    NCT06931340

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Trinity Health Saint Mary Mercy Livonia Hospital (Livonia, MI); Trinity Health IHA Medical Group Hematology Oncology - Canton (Canton, MI)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  31. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

    NCT06632977

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Trinity Health Saint Mary Mercy Livonia Hospital (Livonia, MI); Trinity Health IHA Medical Group Hematology Oncology - Canton (Canton, MI)

    Distance to nearest recruiting site
    ~16 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  32. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: Profound Research LLC at Cancer and Leukemia Center (Sterling Heights, MI)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

    NCT06134232

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Michigan Institute of Urology (Troy, MI)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT06533644

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Michigan Institute of Urology (Troy, MI)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Michigan Institute of Urology, PC (Troy, MI)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Prostate Active Surveillance Study

    NCT00756665

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. EDRN Prostate MRI Biomarker Study

    NCT03784924

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

    NCT04038502

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Ann Arbor Healthcare System, Ann Arbor, MI (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    NCT04787744

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Ann Arbor Healthcare System, Ann Arbor, MI (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

    NCT04812366

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Michigan Health (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

    NCT04986423

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

    NCT05038332

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

    NCT05422911

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: VA Ann Arbor Healthcare System (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe

    NCT05965180

    • Observational
    • Ages 40 to 80 years
    • Sex: Male

    Nearest site: University of Michigan Rogel Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

    NCT06084338

    • Phase 2
    • Ages 18 years and older
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: VA Ann Arbor Healthcare System, Ann Arbor, MI (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

    NCT06228053

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  48. Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

    NCT06616155

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University of Michigan Comprehensive Cancer Center (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  49. A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

    NCT06863272

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan ( Site 0021) (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  50. Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

    NCT06966024

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Michigan (Ann Arbor, MI)

    Distance to nearest recruiting site
    ~36 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.